Strong associations of telomere length and mitochondrial copy number with suicidality and abuse history in adolescent depressed individuals
- PMID: 37735501
- PMCID: PMC10730407
- DOI: 10.1038/s41380-023-02263-0
Strong associations of telomere length and mitochondrial copy number with suicidality and abuse history in adolescent depressed individuals
Abstract
Major depressive disorder (MDD) is highly prevalent in adolescents and is a major risk factor for suicidality. Recent evidence shows that accelerated cellular senescence/aging is associated with psychiatric illness, including depression, in adults. The present study examined if the relationships of telomere length (TL) and mitochondrial DNA copy number (mtDNAcn), two critical indicators of cellular senescence/aging, are altered in depressed adolescents and whether these alterations are associated with suicidality, early-life adversities, and other co-occuring factors. In genomic DNA isolated from 53 adolescents (ages 16-19, 19 MDD with suicide attempt/suicidal ideation [MDD + SI/SA], 14 MDD without SA/SI [MDD-SI/SA], and 20 healthy controls [HC]), TL and mtDNAcn were measured as the ratio between the number of telomere repeats and that of a single-copy nuclear-hemoglobin [HBG] gene or the amount of mtDNA (NADH dehydrogenase, subunit 1) relative to HBG. Our data show that TL was significantly lower, and mtDNAcn was significantly higher in the total MDD group than HC. TL was significantly lower and mtDNAcn was significantly higher in the MDD + SA/SI group than in the HC, whereas there were no differences in the MDD-SI/SA group. TL was positively correlated with mtDNAcn in both HC and MDD-SA/SI groups; however, TL was negatively correlated with mtDNAcn in MDD + SA/SI. Furthermore, TL was negatively correlated with the severity of both depression and anxiety, while mtDNAcn was positively correlated with the severity of prior emotional abuse. Our study indicates that cellular senescence is more advanced in depressed adolescents with suicidal ideation and that childhood emotional abuse may participate in such a process.
© 2023. The Author(s).
Conflict of interest statement
RCS has received grant support from the National Institutes of Health, Patient-Centered Outcomes Research Institute, American Foundation for Suicide Prevention, Acadia Pharmaceuticals, Alkermes, Inc., Allergan, Plc, Alto Pharmaceuticals, Avanir Pharmaceuticals, Inc., Boehringer Ingelheim, Denovo Biopharma, Genomind, InMune Bio, Intra-cellular Therapies, Janssen Pharmaceuticals, LivaNova PLC, Navitor Pharmaceuticals, Neurocrine Biosciences, Neurorx, Novartis Pharmaceuticals, Otsuka Pharmaceutical Company, Sunovion Pharmaceuticals, and Takeda Pharmaceuticals. He has received consulting fees from Acadia Pharmaceuticals, Allergan, Plc, Alphasigma USA, Inc., Boehringer Ingelheim, Cerecor, Inc., Denovo Biopharma, Janssen Pharmaceuticals, Myriad Neuroscience, Neurorx, Novartis AG, Otsuka Pharmaceuticals, Seelos Therapeutics, Inc., Sunovion Pharmaceuticals, and Takeda Pharmaceuticals. Other authors report no conflict of interest.
Figures




Similar articles
-
New generation antidepressants for depression in children and adolescents: a network meta-analysis.Cochrane Database Syst Rev. 2021 May 24;5(5):CD013674. doi: 10.1002/14651858.CD013674.pub2. Cochrane Database Syst Rev. 2021. PMID: 34029378 Free PMC article.
-
Evidence for Altered Electroencephalography Coherence in Depressed Adolescents with Suicidal Ideation and Behaviors.J Child Adolesc Psychopharmacol. 2023 Sep;33(7):287-293. doi: 10.1089/cap.2023.0033. Epub 2023 Sep 5. J Child Adolesc Psychopharmacol. 2023. PMID: 37669028 Free PMC article.
-
Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.Cochrane Database Syst Rev. 2012 Nov 14;11:CD008324. doi: 10.1002/14651858.CD008324.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2014 Nov 30;(11):CD008324. doi: 10.1002/14651858.CD008324.pub3. PMID: 23152255 Updated.
-
Metabolomic Changes in Major Depressive Disorder Adolescent Females with or without Suicide Attempts.Curr Neuropharmacol. 2025;23(7):787-799. doi: 10.2174/1570159X23666250122093451. Curr Neuropharmacol. 2025. PMID: 39844402 Free PMC article.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
Cited by
-
Examining the Biological Impacts of Parent-Child Relationship Dynamics on Preschool-Aged Children who have Experienced Adversity.Dev Psychobiol. 2024 Feb;66(2):e22463. doi: 10.1002/dev.22463. Epub 2024 Jan 28. Dev Psychobiol. 2024. PMID: 38601953 Free PMC article.
-
Alterations in leukocyte telomere length and mitochondrial DNA copy number in benzene poisoning patients.Mol Biol Rep. 2024 Feb 19;51(1):309. doi: 10.1007/s11033-024-09238-6. Mol Biol Rep. 2024. PMID: 38372835
-
Telomere Dynamics in Post-Traumatic Stress Disorder: A Critical Synthesis.Biomedicines. 2025 Feb 18;13(2):507. doi: 10.3390/biomedicines13020507. Biomedicines. 2025. PMID: 40002919 Free PMC article. Review.
-
Increased somatic mosaicism in autosomal and X chromosomes for suicide death.Mol Psychiatry. 2025 Mar;30(3):881-888. doi: 10.1038/s41380-024-02718-y. Epub 2024 Aug 30. Mol Psychiatry. 2025. PMID: 39215187 Free PMC article.
-
Peripheral mitochondrial DNA as a neuroinflammatory biomarker for major depressive disorder.Neural Regen Res. 2025 Jun 1;20(6):1541-1554. doi: 10.4103/NRR.NRR-D-23-01878. Epub 2024 Jun 26. Neural Regen Res. 2025. PMID: 38934398 Free PMC article.
References
-
- Emslie GJ, Ventura D, Korotzer A, Tourkodimitris S. Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial. J Am Acad Child Adolesc Psychiatry. 2009;48:721–9. - PubMed
-
- Daly M. Prevalence of depression among adolescents in the U.S. from 2009 to 2019: analysis of trends by sex, race/ethnicity, and income. J Adolesc Health. 2022;70:496–9. - PubMed
-
- Grossberg A, Rice T. Depression and suicidal behavior in adolescents. Med Clin North Am. 2022;107:169–82. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical